Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $98 to $95.
Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $95
Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $98 to $95.